drugset
drugset / Trial / NCT01123954

Evaluating the Safeness of Trivalent Subunit Inactivated Influenza Vaccines in Preventing Flu on Vietnamese Volunteers

NCT01123954 ↗

Phase 2 Completed 33 enrolled Novartis Vaccines
Non-randomizedSingle-groupOpen-labelPrevention

Summary

The present study will evaluate the safety in healthy people aged 1- 45 years (male and female) after single intramuscular (IM) dose of trivalent subunit inactivated influenza vaccine till the 30-days follow-up period.

Timeline

Start
2010-01
Primary completion
2010-03
Completion
2010-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Quadrivalent influenza vaccine Vaccine — Intramuscular

Indications

influenza